Google
HLN — HALEON PLC (Healthcare >> Drug Manufacturers - Specialty & Generic)
HLN FAQ
What is HLN's P/E ratio?
HALEON PLC (HLN) currently trades at a P/E ratio of 14.02.
What is HLN's ROE?
HALEON PLC reports a Return on Equity (ROE) of 9.94%.
What is HLN's dividend yield?
HALEON PLC offers a dividend yield of 2.13%.
What is HLN's Deepscope Quality Score?
Deepscope rates HLN's overall financial quality at 77 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy HLN?
Deepscope's AI Timing Score for HLN is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does HLN belong to?
HALEON PLC is classified under the Healthcare >> Drug Manufacturers - Specialty & Generic sector on the NYSE exchange.
|
USD 8.70
Price
0.02
(0.23%)
Day Change
|
|
|---|
HLN, ファンダメンタルスコアはgood ( ファンダメンタル = 77) but テクニカルスコアは ...(Sign In to See)...
Loading chart...
- Signal
- OUTPERFORM
- Signal Description
- Company financial health is Good
- Reason
-
ROEが低い
平均ROEが低い
ROAがROEに比べて低い
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not quite good , and ability to make profit is good , ...
| Deepscope 分析 |
|
50% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
1267
|
| Magic Formula Rank by ROE |
1267
|
| Magic Formula Rank by ROIC |
1496
|
| Price | 8.70 |
| PBV / Sector |
2.37 / 2.74
|
| Earning Per Share | 0.36 |
| PE / Sector |
14.02 / 23.29
|
| PEG or PE/Growth / Sector |
0.75 / 0.11
|
| Average 1M Daily Value |
83.08 M
|
| Average 1W Daily Value |
61.02 M
|
| Timing Factors |
|
28% |
| Financial Health |
|
50% |
| ポイントになる統計 |
|
72% |
| 配当 |
|
41% |
| 登録情報 |
| Analyze Date | 2026-06-03 09:11:35 |
| Symbol | HLN |
| Name | HALEON PLC |
| Sector | Healthcare >> Drug Manufacturers - Specialty & Generic |
| Market | NYSE |
| Listed Shares | 4,423.63 M |
| Par Value | N/A |
| Calculated From | YearEnd |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 38,985.16 / 9,635.82 |
| ニュース |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: The Heights, Weybridge, United Kingdom, KT13 0NY
Phone: 44 1932 959 500
Website: https://www.haleon.com
Employees: 24,535
Sector: Healthcare >> Drug Manufacturers - Specialty & Generic
Description: Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Theraflu, and Flonase brands for respiratory issues; and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. Haleon plc was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. The company was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
ME vs SECTOR Healthcare >> Drug Manufacturers - Specialty & Generic
Click a bubble to view stock details · Bubble size represents market capitalization share
